Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
AMPHENOL CORP /DE/
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-48.3% vs price
Base Case (Median)
-11.9% vs price
Bull Case (75th pct.)
16.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $91.43 | 11.0% | High (40%) |
| PE Comparable | $101.27 | 22.9% | Medium (25%) |
| Growth Trajectory DCF | $182.62 | 121.6% | Medium (20%) |
| Graham Number | $31.28 | -62.0% | Low (10%) |
| EV/EBITDA | $51.71 | -37.2% | Medium (20%) |
| EV/FCF | $72.61 | -11.9% | Medium (20%) |
| Earnings Power Value | $33.57 | -59.3% | Medium (50%) |
Based on 7 out of 8 methods, APH appears fairly valued at the current price of $82.40. The base case fair value of $72.61 implies 11.9% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.